Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B
Endpoints News   3 days ago
Read Full Story
Sanofi to snap up Blueprint Medicines and mastocytosis drug Ayvakit for $9.1B  Endpoints NewsSanofi Expands Rare Immunology Portfolio With Blueprint Buyout  Yahoo FinanceSanofi to Buy Blueprint Medicines for Up to $9.5 Billion in Boost to...